Clinical trial
International, Multicenter, Randomized, Single Blind, Placebo-controlled Study of Efficacy and Safety of CITOFLAVIN® in the Acute Period of Head Injury in Adults
NCT04631484 is registered in ClinicalTrials.gov with POLYSAN Scientific & Technological Pharmaceutical Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- International, Multicenter, Randomized, Single Blind, Placebo-controlled Study of Efficacy and Safety of CITOFLAVIN® in the Acute Period of Head Injury in Adults
- Lead sponsor
- POLYSAN Scientific & Technological Pharmaceutical Company
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 22, 2020
- Completion date
- September 24, 2024
- Enrollment
- 166 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
head trauma,closed